3055301-22-6
3055301-22-6
Chemical Structure
Xanthine oxidase-IN-19
- CAS No.: 3055301-22-6
- Formula:C19H16N4O2
- Molecular Weight:332.36
InChIKey: FSGXHNHRPKCKDF-UHFFFAOYSA-N
SMILES: O=C(C1=NN=C(C2=CC3=C(N(C4CCCC4)C=C3C#N)C=C2)C=C1)O
Biological Activity: Xanthine oxidase-IN-19 (Compound 13i) is an orally effective inhibitor of xanthine oxidase (XO), with an IC50 of 0.2 μM. Xanthine oxidase-IN-19 can significantly reduce serum uric acid levels in acute hyperuricemia rat models. Xanthine oxidase-IN-19 can be used for the study of acute hyperuricemia[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Xanthine oxidase-IN-19 | Xanthine oxidase-IN-19 (Compound 13i) is an orally effective inhibitor of xanthine oxidase (XO), with an IC50 of 0.2 μM. Xanthine oxidase-IN-19 can significantly reduce serum uric acid levels in acute hyperuricemia rat models. Xanthine oxidase-IN-19 can be used for the study of acute hyperuricemia. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
